Association of genetic variants in m1A modification core genes and neuroblastoma risk

Neuroblastoma tightly linked with genetic abnormality. The core genes responsible for RNA N<sup>1</sup>-methyladenosine (m<sup>1</sup>A) modification are critical in tumor development. Nevertheless, few reports revealed the function of m<sup>1</sup>A modification core gene polymorphisms and the neuroblastoma risk. We carried out this study to verify the association of 12 single-nucleotide polymorphisms (SNPs) with neuroblastoma susceptibility. This study recruited 898 cases with newly diagnosed neuroblastoma and 1734 Healthy controls from eight medical centers. We selected 12 SNPs from m<sup>1</sup>A modification genes ALKBH1, TRMT6, TRMT61B, and TRMT10C, and genotypes were determined by the TaqMan method. We used univariable and multivariable logistic regression models to analyze the association of SNPs with neuroblastoma risk, followed by stratified analysis. Statistical analysis showed that TRMT6 rs236170 GG (AOR = 1.23, 95% CI = 1.02-1.50, P = 0.034), rs451571 CC (AOR = 1.46, 95% CI = 1.01-2.11, P = 0.043), rs236188 AA (AOR = 2.65, 95% CI = 1.16-6.07, P = 0.021), rs236110 AA (AOR = 1.91, 95% CI = 1.29-2.82, P = 0.001), and ALKBH1 rs6494 AA (AOR = 4.27, 95% CI = 1.31-13.93, P = 0.016), rs176942 GG (AOR = 1.98, 95% CI = 1.35-2.89, P = 0.0005) were neuroblastoma risk variants; the ALKBH1 rs1048147 CC (AOR = 0.80, 95% CI = 0.68-0.94, P = 0.007) was inverse associated with neuroblastoma risk. The eQTL analysis showed that functional annotation of rs6494 T > A may be potential function variants through decreasing ALKBH1 gene expression mRNA, rs451571 T > C, rs236188 G > A, rs236110 C > A are associated with neuroblastoma risk through increasing the expression of its nearby genes RP5-967N21.11 and lowering the expression of MCM8. Our research showed some SNPs in the m<sup>1</sup>A modification core genes are related to neuroblastoma.Clinical perspectives(i) Few reports have revealed the function of m<sup>1</sup>A modification core gene polymorphisms in neuroblastoma risk.(ii) After genotyping 12 SNPs with potential functions in four m<sup>1</sup>A modification core genes in children with neuroblastoma and healthy controls, we found several neuroblastoma predisposition loci, including TRMT6 rs236170, rs451571, rs236188, rs236110, and ALKBH1 rs6494, rs176942, and rs1048147. The eQTL assessment demonstrated that rs6494 T > A may be a potential functional variant by decreasing ALKBH1 mRNA expression.(iii) Our research is the first to reveal m<sup>1</sup>A modification core gene SNPs and neuroblastoma risk.

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2025-10-17
DOI
https://doi.org/10.1186/s12885-025-14984-2
Primary Topic
Neuroblastoma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association of genetic variants in m1A modification core genes and neuroblastoma risk

Jiwen Cheng, Jinhong Zhu, Suhong Li, Lei Lin et al.
BMC Cancer
Neuroblastoma Research and Treatments
article

Association of genetic variants in m1A modification core genes and neuroblastoma risk

Jiwen Cheng, Jinhong Zhu, Suhong Li, Lei Lin, Wenhan Yang, Yong Li, Xinxin Zhang, Zhenjian Zhuo, Liping Chen, Haixia Zhou, Jiao Zhang, Zhonghua Yang, Jing He, Siqi Dong, Li Li, Susu Jiang, Wenli Zhang
article en

Abstract

Neuroblastoma tightly linked with genetic abnormality. The core genes responsible for RNA N<sup>1</sup>-methyladenosine (m<sup>1</sup>A) modification are critical in tumor development. Nevertheless, few reports revealed the function of m<sup>1</sup>A modification core gene polymorphisms and the neuroblastoma risk. We carried out this study to verify the association of 12 single-nucleotide polymorphisms (SNPs) with neuroblastoma susceptibility. This study recruited 898 cases with newly diagnosed neuroblastoma and 1734 Healthy controls from eight medical centers. We selected 12 SNPs from m<sup>1</sup>A modification genes ALKBH1, TRMT6, TRMT61B, and TRMT10C, and genotypes were determined by the TaqMan method. We used univariable and multivariable logistic regression models to analyze the association of SNPs with neuroblastoma risk, followed by stratified analysis. Statistical analysis showed that TRMT6 rs236170 GG (AOR = 1.23, 95% CI = 1.02-1.50, P = 0.034), rs451571 CC (AOR = 1.46, 95% CI = 1.01-2.11, P = 0.043), rs236188 AA (AOR = 2.65, 95% CI = 1.16-6.07, P = 0.021), rs236110 AA (AOR = 1.91, 95% CI = 1.29-2.82, P = 0.001), and ALKBH1 rs6494 AA (AOR = 4.27, 95% CI = 1.31-13.93, P = 0.016), rs176942 GG (AOR = 1.98, 95% CI = 1.35-2.89, P = 0.0005) were neuroblastoma risk variants; the ALKBH1 rs1048147 CC (AOR = 0.80, 95% CI = 0.68-0.94, P = 0.007) was inverse associated with neuroblastoma risk. The eQTL analysis showed that functional annotation of rs6494 T > A may be potential function variants through decreasing ALKBH1 gene expression mRNA, rs451571 T > C, rs236188 G > A, rs236110 C > A are associated with neuroblastoma risk through increasing the expression of its nearby genes RP5-967N21.11 and lowering the expression of MCM8. Our research showed some SNPs in the m<sup>1</sup>A modification core genes are related to neuroblastoma.Clinical perspectives(i) Few reports have revealed the function of m<sup>1</sup>A modification core gene polymorphisms in neuroblastoma risk.(ii) After genotyping 12 SNPs with potential functions in four m<sup>1</sup>A modification core genes in children with neuroblastoma and healthy controls, we found several neuroblastoma predisposition loci, including TRMT6 rs236170, rs451571, rs236188, rs236110, and ALKBH1 rs6494, rs176942, and rs1048147. The eQTL assessment demonstrated that rs6494 T > A may be a potential functional variant by decreasing ALKBH1 mRNA expression.(iii) Our research is the first to reveal m<sup>1</sup>A modification core gene SNPs and neuroblastoma risk.

BMC CancerVol. 25(1)
Harbin Medical University (CN), Shenzhen University (CN), Guangdong Pharmaceutical University (CN), Peking University (CN), Wenzhou Medical University (CN), Kunming Children's Hospital (CN), Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University (CN), Third Affiliated Hospital of Harbin Medical University (CN), Guangzhou Women and Children Medical Center (CN), People's Hospital of Xinjiang Uygur Autonomous Region (CN), Peking University Shenzhen Hospital (CN), Second Affiliated Hospital of Xi'an Jiaotong University (CN), Hunan Children's Hospital (CN), First Affiliated Hospital of Zhengzhou University (CN), China Medical University (CN), Guangzhou Medical University (CN)
National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province
Openalex Percentile: Top 58%
Neuroblastoma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.